Before you sell to, join or invest in Dermata Therapeutics, Inc.
MentionFox check on Dermata Therapeutics, Inc.: only 1 source on file so far (checked 8 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/dermata-therapeutics-inc-form-d-26000797
Check Dermata Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Dermata Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-01-07.
Dermata Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on January 7, 2026. Dermata Therapeutics, Inc. trades on Nasdaq as DRMA. The filing reports $4.12M sold. Its industry group is Biotechnology. It names Gerald Proehl (Executive Officer, Director), Kyri Van Hoose (Executive Officer), Christopher Nardo (Executive Officer) (SEC Form D, January 7, 2026).
In its own words: “Tome is a skincare company forging a timeless ingredient with modern science to bring a first-of-its-kind, weekly treatment made for home.” (tomeskincare.com, checked November 1, 2026)
Who owns Dermata Therapeutics, Inc.?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Dermata Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-01-07 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Dermata Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Dermata Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in January 2026, largest first.
Get an email when Dermata Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Dermata Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Dermata Therapeutics, Inc. →Get the full cited report on Dermata Therapeutics, Inc.
What the filing shows about Dermata Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Dermata Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Dermata Therapeutics, Inc.'s address as 3525 Del Mar Heights Rd., #322, San Diego, CA 92130.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Dermata Therapeutics, Inc. See pricing
Dermata Therapeutics, Inc. is a registered filer with the SEC (CIK 1853816) and has filed since 2023-06-12. 5 filings are on record, the latest on 2026-01-07.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Dermata Therapeutics, Inc.'s Form D of 2026-01-07 names Gerald Proehl, Kyri Van Hoose, Christopher Nardo and 8 more as its officers, directors or promoters.
Its new offerings report $10.17M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week. The dot is this raise, $4.12M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Some of the proceeds may be used for working capital and general corporate purposes, including the payment of salaries and other fees to those listed in Item 3.
Gerald Proehl is named as Executive Officer and Director on the Form D that Dermata Therapeutics, Inc. filed with the SEC on 7 January 2026, one of 11 people that filing names.
Kyri Van Hoose is named as Executive Officer on the Form D that Dermata Therapeutics, Inc. filed with the SEC on 7 January 2026, one of 11 people that filing names.
Christopher Nardo is named as Executive Officer on the Form D that Dermata Therapeutics, Inc. filed with the SEC on 7 January 2026, one of 11 people that filing names.
Maria Bedoya Toro Munera is named as Executive Officer on the Form D that Dermata Therapeutics, Inc. filed with the SEC on 7 January 2026, one of 11 people that filing names.
David Hale is named as Director on the Form D that Dermata Therapeutics, Inc. filed with the SEC on 7 January 2026, one of 11 people that filing names.
Wendell Wierenga is named as Director on the Form D that Dermata Therapeutics, Inc. filed with the SEC on 7 January 2026, one of 11 people that filing names.
Andrew Sandler is named as Director on the Form D that Dermata Therapeutics, Inc. filed with the SEC on 7 January 2026, one of 11 people that filing names.
Brittany Bradrick is named as Director on the Form D that Dermata Therapeutics, Inc. filed with the SEC on 7 January 2026, one of 11 people that filing names.
Kathleen Scott is named as Director on the Form D that Dermata Therapeutics, Inc. filed with the SEC on 7 January 2026, one of 11 people that filing names.
Mary Fisher is named as Director on the Form D that Dermata Therapeutics, Inc. filed with the SEC on 7 January 2026, one of 11 people that filing names.
Steven Mento is named as Director on the Form D that Dermata Therapeutics, Inc. filed with the SEC on 7 January 2026, one of 11 people that filing names.
11 people named on the filing — 4 holding an executive role and 7 as directors only.
Named as of the 2026-01-07 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Dermata Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Dermata Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Dermata Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Dermata Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Dermata Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Dermata Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Diego
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/dermata-therapeutics-inc-form-d-26000797